Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: KBV Research | PRODUCT CODE: 1461815

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1461815

Europe Hyperpigmentation Treatment Market Size, Share & Trends Analysis Report By Treatment Type, By End User (Dermatological Clinics, Hospitals, and Others), By Disorder Type (Melasma, Age Spot, and Others). By Country and Growth Forecast, 2023 - 2030

PUBLISHED:
PAGES: 115 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 1500
PDF (Site License)
USD 1800
PDF (Enterprisewide License)
USD 2520

Add to Cart

The Europe Hyperpigmentation Treatment Market would witness market growth of 7.8% CAGR during the forecast period (2023-2030).

The Germany market dominated the Europe Hyperpigmentation Treatment Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $567.4 million by 2030. The UK market is exhibiting a CAGR of 6.8% during (2023 - 2030). Additionally, The France market would experience a CAGR of 8.6% during (2023 - 2030).

One of the primary drivers behind the heightened adoption of hyperpigmentation treatments is the increased awareness of skincare practices. The proliferation of information through various channels, including social media, beauty blogs, and online forums, has educated consumers about different skin conditions and the available treatment options. As individuals become more informed about the causes and consequences of hyperpigmentation, they are more likely to seek professional solutions to address these concerns.

Changing beauty standards plays a pivotal role in the adoption of hyperpigmentation treatments. While a growing emphasis is on embracing diverse skin tones and celebrating natural beauty, the desire for clear, even skin remains a prevalent aesthetic goal. The evolving standards, marked by inclusivity and acceptance of various skin types, contribute to a broader audience seeking hyperpigmentation treatments to achieve skin clarity and uniformity. The availability of information significantly influences the growing use of hyperpigmentation treatments. Online resources provide individuals with a wealth of information about available treatment options, potential side effects, and real-life testimonials. This democratization of information empowers consumers to make informed decisions about their skincare, leading to a higher likelihood of seeking professional treatments for hyperpigmentation.

As per the data released by Eurostat, in 2022, the median equivalized disposable income in the EU was 18,706 purchasing power standards (PPS) per inhabitant, increasing from 18,011 PPS recorded in 2021. At the national level, the EU countries with the highest median disposable incomes in 2022 were Luxembourg (33 214 PPS), the Netherlands (25 437 PPS), Austria (25 119 PPS), Belgium (24 142 PPS), Denmark (23 244 PPS) and Germany (23 197 PPS). Thus, all these factors will boost the regional market's expansion in the coming years.

Based on Treatment Type, the market is segmented into Topical Agent, Photo Therapy, and Microdermabrasion. Based on End User, the market is segmented into Dermatological Clinics, Hospitals, and Others. Based on Disorder Type, the market is segmented into Melasma, Age Spot, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

List of Key Companies Profiled

  • Vivier Pharma Inc.
  • Pierre Fabre S.A
  • Aerolase
  • L'Oreal S.A.
  • CP Skin Health Group, Inc. (The Colgate Palmolive Company)
  • Trophy Skin Products LLC
  • The Alchemee LLC (Taro Pharmaceutical Industries Ltd.)
  • Episciences, Inc.
  • The Procter and Gamble Company
  • Galderma S.A.

Europe Hyperpigmentation Treatment Market Report Segmentation

By Treatment Type

  • Topical Agent
  • Photo Therapy
  • Microdermabrasion

By End User

  • Dermatological Clinics
  • Hospitals
  • Others

By Disorder Type

  • Melasma
  • Age Spot
  • Others

By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Table of Contents

Chapter 1.Market Scope & Methodology

  • 1.1Market Definition
  • 1.2Objectives
  • 1.3Market Scope
  • 1.4Segmentation
    • 1.4.1Europe Hyperpigmentation Treatment Market, by Treatment Type
    • 1.4.2Europe Hyperpigmentation Treatment Market, by End User
    • 1.4.3Europe Hyperpigmentation Treatment Market, by Disorder Type
    • 1.4.4Europe Hyperpigmentation Treatment Market, by Country
  • 1.5Methodology for the research

Chapter 2.Market at a Glance

  • 2.1Key Highlights

Chapter 3.Market Overview

  • 3.1Introduction
    • 3.1.1Overview
      • 3.1.1.1Market Composition and Scenario
  • 3.2Key Factors Impacting the Market
    • 3.2.1Market Drivers
    • 3.2.2Market Restraints
    • 3.2.3Market Opportunities
    • 3.2.4Market Challenges
  • 3.3Porter's Five Forces Analysis

Chapter 4.Europe Hyperpigmentation Treatment Market by Treatment Type

  • 4.1Europe Topical Agent Market by Country
  • 4.2Europe Photo Therapy Market by Country
  • 4.3Europe Microdermabrasion Market by Country

Chapter 5.Europe Hyperpigmentation Treatment Market by End User

  • 5.1Europe Dermatological Clinics Market by Country
  • 5.2Europe Hospitals Market by Country
  • 5.3Europe Others Market by Country

Chapter 6.Europe Hyperpigmentation Treatment Market by Disorder Type

  • 6.1Europe Melasma Market by Country
  • 6.2Europe Age Spot Market by Country
  • 6.3Europe Others Market by Country

Chapter 7.Europe Hyperpigmentation Treatment Market by Country

  • 7.1Germany Hyperpigmentation Treatment Market
    • 7.1.1Germany Hyperpigmentation Treatment Market by Treatment Type
    • 7.1.2Germany Hyperpigmentation Treatment Market by End User
    • 7.1.3Germany Hyperpigmentation Treatment Market by Disorder Type
  • 7.2UK Hyperpigmentation Treatment Market
    • 7.2.1UK Hyperpigmentation Treatment Market by Treatment Type
    • 7.2.2UK Hyperpigmentation Treatment Market by End User
    • 7.2.3UK Hyperpigmentation Treatment Market by Disorder Type
  • 7.3France Hyperpigmentation Treatment Market
    • 7.3.1France Hyperpigmentation Treatment Market by Treatment Type
    • 7.3.2France Hyperpigmentation Treatment Market by End User
    • 7.3.3France Hyperpigmentation Treatment Market by Disorder Type
  • 7.4Russia Hyperpigmentation Treatment Market
    • 7.4.1Russia Hyperpigmentation Treatment Market by Treatment Type
    • 7.4.2Russia Hyperpigmentation Treatment Market by End User
    • 7.4.3Russia Hyperpigmentation Treatment Market by Disorder Type
  • 7.5Spain Hyperpigmentation Treatment Market
    • 7.5.1Spain Hyperpigmentation Treatment Market by Treatment Type
    • 7.5.2Spain Hyperpigmentation Treatment Market by End User
    • 7.5.3Spain Hyperpigmentation Treatment Market by Disorder Type
  • 7.6Italy Hyperpigmentation Treatment Market
    • 7.6.1Italy Hyperpigmentation Treatment Market by Treatment Type
    • 7.6.2Italy Hyperpigmentation Treatment Market by End User
    • 7.6.3Italy Hyperpigmentation Treatment Market by Disorder Type
  • 7.7Rest of Europe Hyperpigmentation Treatment Market
    • 7.7.1Rest of Europe Hyperpigmentation Treatment Market by Treatment Type
    • 7.7.2Rest of Europe Hyperpigmentation Treatment Market by End User
    • 7.7.3Rest of Europe Hyperpigmentation Treatment Market by Disorder Type

Chapter 8.Company Profiles

  • 8.1Vivier Pharma Inc.
    • 8.1.1Company Overview
    • 8.1.2SWOT Analysis
  • 8.2Pierre Fabre S.A
    • 8.2.1Company Overview
    • 8.2.2Recent strategies and developments:
      • 8.2.2.1Partnerships, Collaborations, and Agreements:
    • 8.2.3SWOT Analysis
  • 8.3Aerolase
    • 8.3.1Company Overview
    • 8.3.2SWOT Analysis
  • 8.4L'Oreal S.A.
    • 8.4.1Company Overview
    • 8.4.2Financial Analysis
    • 8.4.3Segmental and Regional Analysis
    • 8.4.4Recent strategies and developments:
      • 8.4.4.1Partnerships, Collaborations, and Agreements:
    • 8.4.5SWOT Analysis
  • 8.5The Procter & Gamble Company
    • 8.5.1Company Overview
    • 8.5.2Financial Analysis
    • 8.5.3Segmental and Regional Analysis
    • 8.5.4Research & Development Expense
    • 8.5.5SWOT Analysis
  • 8.6Galderma S.A.
    • 8.6.1Company Overview
    • 8.6.2SWOT Analysis
  • 8.7CP Skin Health Group, Inc. (The Colgate Palmolive Company)
    • 8.7.1Company Overview
    • 8.7.2Financial Analysis
    • 8.7.3Segmental and Regional Analysis
    • 8.7.4Research & Development Expenses
    • 8.7.5SWOT Analysis
  • 8.8Trophy Skin Products LLC
    • 8.8.1Company Overview
    • 8.8.2SWOT Analysis
  • 8.9The Alchemee LLC (Taro Pharmaceutical Industries Ltd.)
    • 8.9.1Company Overview
    • 8.9.2Financial Analysis
    • 8.9.3Regional Analysis
    • 8.9.4Research & Development Expenses
    • 8.9.5SWOT Analysis
  • 8.10.Episciences, Inc.
    • 8.10.1Company Overview
    • 8.10.2SWOT Analysis

LIST OF TABLES

  • TABLE 1Europe Hyperpigmentation Treatment Market, 2019 - 2022, USD Million
  • TABLE 2Europe Hyperpigmentation Treatment Market, 2023 - 2030, USD Million
  • TABLE 3Europe Hyperpigmentation Treatment Market by Treatment Type, 2019 - 2022, USD Million
  • TABLE 4Europe Hyperpigmentation Treatment Market by Treatment Type, 2023 - 2030, USD Million
  • TABLE 5Europe Topical Agent Market by Country, 2019 - 2022, USD Million
  • TABLE 6Europe Topical Agent Market by Country, 2023 - 2030, USD Million
  • TABLE 7Europe Photo Therapy Market by Country, 2019 - 2022, USD Million
  • TABLE 8Europe Photo Therapy Market by Country, 2023 - 2030, USD Million
  • TABLE 9Europe Microdermabrasion Market by Country, 2019 - 2022, USD Million
  • TABLE 10Europe Microdermabrasion Market by Country, 2023 - 2030, USD Million
  • TABLE 11Europe Hyperpigmentation Treatment Market by End User, 2019 - 2022, USD Million
  • TABLE 12Europe Hyperpigmentation Treatment Market by End User, 2023 - 2030, USD Million
  • TABLE 13Europe Dermatological Clinics Market by Country, 2019 - 2022, USD Million
  • TABLE 14Europe Dermatological Clinics Market by Country, 2023 - 2030, USD Million
  • TABLE 15Europe Hospitals Market by Country, 2019 - 2022, USD Million
  • TABLE 16Europe Hospitals Market by Country, 2023 - 2030, USD Million
  • TABLE 17Europe Others Market by Country, 2019 - 2022, USD Million
  • TABLE 18Europe Others Market by Country, 2023 - 2030, USD Million
  • TABLE 19Europe Hyperpigmentation Treatment Market by Disorder Type, 2019 - 2022, USD Million
  • TABLE 20Europe Hyperpigmentation Treatment Market by Disorder Type, 2023 - 2030, USD Million
  • TABLE 21Europe Melasma Market by Country, 2019 - 2022, USD Million
  • TABLE 22Europe Melasma Market by Country, 2023 - 2030, USD Million
  • TABLE 23Europe Age Spot Market by Country, 2019 - 2022, USD Million
  • TABLE 24Europe Age Spot Market by Country, 2023 - 2030, USD Million
  • TABLE 25Europe Others Market by Country, 2019 - 2022, USD Million
  • TABLE 26Europe Others Market by Country, 2023 - 2030, USD Million
  • TABLE 27Europe Hyperpigmentation Treatment Market by Country, 2019 - 2022, USD Million
  • TABLE 28Europe Hyperpigmentation Treatment Market by Country, 2023 - 2030, USD Million
  • TABLE 29Germany Hyperpigmentation Treatment Market, 2019 - 2022, USD Million
  • TABLE 30Germany Hyperpigmentation Treatment Market, 2023 - 2030, USD Million
  • TABLE 31Germany Hyperpigmentation Treatment Market by Treatment Type, 2019 - 2022, USD Million
  • TABLE 32Germany Hyperpigmentation Treatment Market by Treatment Type, 2023 - 2030, USD Million
  • TABLE 33Germany Hyperpigmentation Treatment Market by End User, 2019 - 2022, USD Million
  • TABLE 34Germany Hyperpigmentation Treatment Market by End User, 2023 - 2030, USD Million
  • TABLE 35Germany Hyperpigmentation Treatment Market by Disorder Type, 2019 - 2022, USD Million
  • TABLE 36Germany Hyperpigmentation Treatment Market by Disorder Type, 2023 - 2030, USD Million
  • TABLE 37UK Hyperpigmentation Treatment Market, 2019 - 2022, USD Million
  • TABLE 38UK Hyperpigmentation Treatment Market, 2023 - 2030, USD Million
  • TABLE 39UK Hyperpigmentation Treatment Market by Treatment Type, 2019 - 2022, USD Million
  • TABLE 40UK Hyperpigmentation Treatment Market by Treatment Type, 2023 - 2030, USD Million
  • TABLE 41UK Hyperpigmentation Treatment Market by End User, 2019 - 2022, USD Million
  • TABLE 42UK Hyperpigmentation Treatment Market by End User, 2023 - 2030, USD Million
  • TABLE 43UK Hyperpigmentation Treatment Market by Disorder Type, 2019 - 2022, USD Million
  • TABLE 44UK Hyperpigmentation Treatment Market by Disorder Type, 2023 - 2030, USD Million
  • TABLE 45France Hyperpigmentation Treatment Market, 2019 - 2022, USD Million
  • TABLE 46France Hyperpigmentation Treatment Market, 2023 - 2030, USD Million
  • TABLE 47France Hyperpigmentation Treatment Market by Treatment Type, 2019 - 2022, USD Million
  • TABLE 48France Hyperpigmentation Treatment Market by Treatment Type, 2023 - 2030, USD Million
  • TABLE 49France Hyperpigmentation Treatment Market by End User, 2019 - 2022, USD Million
  • TABLE 50France Hyperpigmentation Treatment Market by End User, 2023 - 2030, USD Million
  • TABLE 51France Hyperpigmentation Treatment Market by Disorder Type, 2019 - 2022, USD Million
  • TABLE 52France Hyperpigmentation Treatment Market by Disorder Type, 2023 - 2030, USD Million
  • TABLE 53Russia Hyperpigmentation Treatment Market, 2019 - 2022, USD Million
  • TABLE 54Russia Hyperpigmentation Treatment Market, 2023 - 2030, USD Million
  • TABLE 55Russia Hyperpigmentation Treatment Market by Treatment Type, 2019 - 2022, USD Million
  • TABLE 56Russia Hyperpigmentation Treatment Market by Treatment Type, 2023 - 2030, USD Million
  • TABLE 57Russia Hyperpigmentation Treatment Market by End User, 2019 - 2022, USD Million
  • TABLE 58Russia Hyperpigmentation Treatment Market by End User, 2023 - 2030, USD Million
  • TABLE 59Russia Hyperpigmentation Treatment Market by Disorder Type, 2019 - 2022, USD Million
  • TABLE 60Russia Hyperpigmentation Treatment Market by Disorder Type, 2023 - 2030, USD Million
  • TABLE 61Spain Hyperpigmentation Treatment Market, 2019 - 2022, USD Million
  • TABLE 62Spain Hyperpigmentation Treatment Market, 2023 - 2030, USD Million
  • TABLE 63Spain Hyperpigmentation Treatment Market by Treatment Type, 2019 - 2022, USD Million
  • TABLE 64Spain Hyperpigmentation Treatment Market by Treatment Type, 2023 - 2030, USD Million
  • TABLE 65Spain Hyperpigmentation Treatment Market by End User, 2019 - 2022, USD Million
  • TABLE 66Spain Hyperpigmentation Treatment Market by End User, 2023 - 2030, USD Million
  • TABLE 67Spain Hyperpigmentation Treatment Market by Disorder Type, 2019 - 2022, USD Million
  • TABLE 68Spain Hyperpigmentation Treatment Market by Disorder Type, 2023 - 2030, USD Million
  • TABLE 69Italy Hyperpigmentation Treatment Market, 2019 - 2022, USD Million
  • TABLE 70Italy Hyperpigmentation Treatment Market, 2023 - 2030, USD Million
  • TABLE 71Italy Hyperpigmentation Treatment Market by Treatment Type, 2019 - 2022, USD Million
  • TABLE 72Italy Hyperpigmentation Treatment Market by Treatment Type, 2023 - 2030, USD Million
  • TABLE 73Italy Hyperpigmentation Treatment Market by End User, 2019 - 2022, USD Million
  • TABLE 74Italy Hyperpigmentation Treatment Market by End User, 2023 - 2030, USD Million
  • TABLE 75Italy Hyperpigmentation Treatment Market by Disorder Type, 2019 - 2022, USD Million
  • TABLE 76Italy Hyperpigmentation Treatment Market by Disorder Type, 2023 - 2030, USD Million
  • TABLE 77Rest of Europe Hyperpigmentation Treatment Market, 2019 - 2022, USD Million
  • TABLE 78Rest of Europe Hyperpigmentation Treatment Market, 2023 - 2030, USD Million
  • TABLE 79Rest of Europe Hyperpigmentation Treatment Market by Treatment Type, 2019 - 2022, USD Million
  • TABLE 80Rest of Europe Hyperpigmentation Treatment Market by Treatment Type, 2023 - 2030, USD Million
  • TABLE 81Rest of Europe Hyperpigmentation Treatment Market by End User, 2019 - 2022, USD Million
  • TABLE 82Rest of Europe Hyperpigmentation Treatment Market by End User, 2023 - 2030, USD Million
  • TABLE 83Rest of Europe Hyperpigmentation Treatment Market by Disorder Type, 2019 - 2022, USD Million
  • TABLE 84Rest of Europe Hyperpigmentation Treatment Market by Disorder Type, 2023 - 2030, USD Million
  • TABLE 85Key Information - Vivier Pharma Inc.
  • TABLE 86Key Information - Pierre Fabre S.A
  • TABLE 87Key Information - aerolase
  • TABLE 88Key Information - L'Oreal S.A.
  • TABLE 89Key Information - The Procter & Gamble Company
  • TABLE 90Key Information - Galderma S.A.
  • TABLE 91Key Information - CP Skin Health Group, inc.
  • TABLE 92Key Information - Trophy Skin Products LLC
  • TABLE 93Key Information - The Alchemee LLC
  • TABLE 94Key Information - Episciences, Inc.
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!